Discontinuation report JAMP-SILDENAFIL
Report ID | 169006 |
Drug Identification Number | 02405679 |
Brand name | JAMP-SILDENAFIL |
Common or Proper name | Sildenafil Citrate Tablets |
Company Name | JAMP PHARMA CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SILDENAFIL |
Strength(s) | 50.0MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 4 |
ATC code | G04BE |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-09-07 |
Remaining supply date | 2021-11-30 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2022-09-09 | English | Compare |
v2 | 2022-09-09 | French | Compare |
Showing 1 to 2 of 2